Crossmark

Low-dose IL-34 has no effect on osteoclastogenesis but promotes osteogenesis of hBMSCs partly via activation of the PI3K/AKT and ERK signaling pathways

Crossref DOI link: https://doi.org/10.1186/s13287-021-02263-3

Published Online: 2021-05-04

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Jianxiang

Fu, Lifeng

Bai, Jinwu

Zhong, Huiming

Kuang, Zhihui

Zhou, Chengwei

Hu, Bin

Ni, Licheng

Ying, Li

Chen, Erman

Zhang, Wei

Wu, Jiaqi

Xue, Deting

Li, Weixu

Pan, Zhijun https://orcid.org/0000-0002-4618-5990
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81672147, 81874007)
License Information

Text and Data Mining valid from 2021-05-04

Version of Record valid from 2021-05-04
More Information

Article History

Received: 30 September 2020

Accepted: 2 March 2021

First Online: 4 May 2021

Declarations

:

: All animal experiments were in accordance with the Animal Care and Use Committee guidelines of Zhejiang University. All experimental procedures were in accordance with the Institutional Animal Care Use Committee at Zhejiang University.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below